Latest from research and the clinic.
New trial results, patient questions answered, India updates, and plain-language commentary on Lutetium therapy. Updated weekly. Reviewed by medical oncologists.
PSMAfore Results: Lu-177 PSMA therapy Before Chemotherapy Shows Benefit
What the PSMAfore trial actually found, and what it means for prostate cancer patients deciding when to start Lutetium therapy. New evidence suggests earlier is often better.
Can I Hug My Grandchildren After a Lutetium Infusion?
Yes — with simple precautions for the first few days. Here's what radiation safety actually looks like at home, in plain language.
Why India is becoming the world's destination for Lutetium therapy
Decades of nuclear medicine expertise, transparent pricing, short wait times — and what makes our center in India stand out for international patients.
How we choose what to write about
We focus on three kinds of content:
- Trial results that change practice — plain-language summaries of new evidence, with honest framing of what it does and doesn't mean
- Patient questions we hear repeatedly — taking the most common navigator-conversation questions and answering them publicly
- India updates — new centers, new approvals, new policies that affect Indian and India-bound patients
Every clinical post is reviewed by an oncologist or nuclear medicine physician before publication.
Have a specific question about your situation?
A free 20-minute conversation with a patient navigator can help you understand whether Lutetium therapy fits your case, what questions to ask your oncologist, and which centers might be right for you.
Navigators don't diagnose or prescribe. They help you have better conversations with the doctors who do.